Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies S.A.
  6. News
  7. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES S.A.

(DBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Higher in Friday Trading

05/07/2021 | 11:07am EDT


ę MT Newswires 2021
All news about DBV TECHNOLOGIES S.A.
06/14European ADRs Move Higher in Monday Trading
MT
06/09European ADRs Slightly Higher Wednesday With Biotechs Leading While Miners Dr..
MT
06/02GLOBAL MARKETS LIVE : Tesla, AB Volvo, Credit Suisse, Amazon, Tyson Foods...
06/01DBV TECHNOLOGIESá : to Present at Upcoming Investor Conferences
PU
05/28European ADRs Move Higher in Friday Trading
MT
05/26European ADRs Trading Nearly Flat Wednesday; IDEX a Standout
MT
05/24DBV TECHNOLOGIESá : I.—CHARACTERISTIC FEATURES OF THE COMPANY (Form 8-K)
PU
05/24DBV TECHNOLOGIES S.A.á : Amendments to Articles of Inc. or Bylaws; Change in Fis..
AQ
05/21European ADRs Move Higher in Friday Trading
MT
05/20DBV TECHNOLOGIES S Aá : AGM 2021 – Quorum
PU
More news
Financials
Sales 2021 9,60 M 11,4 M 11,4 M
Net income 2021 -101 M -120 M -120 M
Net cash 2021 73,7 M 87,3 M 87,3 M
P/E ratio 2021 -5,85x
Yield 2021 -
Capitalization 568 M 673 M 673 M
EV / Sales 2021 51,5x
EV / Sales 2022 18,5x
Nbr of Employees 104
Free-Float 91,2%
Chart DBV TECHNOLOGIES S.A.
Duration : Period :
DBV Technologies S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES S.A.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 11,30 €
Last Close Price 10,34 €
Spread / Highest target 45,1%
Spread / Average Target 9,34%
Spread / Lowest Target -23,6%
EPS Revisions
Managers and Directors
NameTitle
Daniel TassÚ Chief Executive Officer & Executive Director
SÚbastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Pharis Mohideen Chief Medical Officer
Pascal Wotling Chief Technical Operations Officer